RASPBERRY FRAGRANCE

Hazard statements (CLP)

H412

Code

Statements

H412

Harmful to aquatic life with long lasting effects

SECTION 2: Hazards identification

Signal word

None

Hazard statements

H412, Harmful to aquatic life with long lasting effects.

Additional information

EUH208, Contains 3-(2H-1,3-BENZODIOXOL-5-YL)-2-METHYLPROPANAL, DIMETHYL-3- CYCLOHEXENE-1-CARBALDEHYDE, GERANYL ACETATE, LIMONENE, LINALYL ACETATE, METHYL CINNAMATE, NERYL ACETATE, TRANS-ROSE KETONE-2. May produce an allergic reaction.

Precautionary statements

P273, Avoid release to the environment. P501, Dispose of contents/container to approved disposal site, in accordance with local regulations.

Hazard pictograms

None

Other hazards

Sensitisers declared on a CLP 3-(2H-1,3-BENZODIOXOL-5-YL)-2-METHYLPROPANAL, Hazard Label: DIMETHYL-3-CYCLOHEXENE-1-CARBALDEHYDE, GERANYL ACETATE, LIMONENE, LINALYL ACETATE, METHYL CINNAMATE, NERYL ACETATE, TRANS-ROSE KETONE-2 Hydrocarbon Concentration %: 0.000%

2.1 Classification of the substance or mixture

Classification under Regulation (EC) No 1272/2008 Class and category of Hazardous to the Aquatic Environment - Long-term Hazard Category 3 danger: H412, Harmful to aquatic life with long lasting effects. 2.2 Label elements Classification under Regulation (EC) No 1272/2008 Signal word: None Hazard statements: H412, Harmful to aquatic life with long lasting effects. Supplemental EUH208, Contains 3-(2H-1,3-BENZODIOXOL-5-YL)-2-METHYLPROPANAL, DIMETHYL-3- Information: CYCLOHEXENE-1-CARBALDEHYDE, GERANYL ACETATE, LIMONENE, LINALYL ACETATE, METHYL CINNAMATE, NERYL ACETATE, TRANS-ROSE KETONE-2. May produce an allergic reaction. 27 Precautionary P273, Avoid release to the environment. statements: P501, Dispose of contents/container to approved disposal site, in accordance with local regulations. Pictograms: None 2.3 Other hazards Other hazards: Sensitisers declared on a CLP 3-(2H-1,3-BENZODIOXOL-5-YL)-2-METHYLPROPANAL, Hazard Label: DIMETHYL-3-CYCLOHEXENE-1-CARBALDEHYDE, GERANYL ACETATE, LIMONENE, LINALYL ACETATE, METHYL CINNAMATE, NERYL ACETATE, TRANS-ROSE KETONE-2 Hydrocarbon Concentration %: 0.000% Section 3. Composition / information on ingredients 3.2 Mixtures Contains: Name Specific Conc. CAS EC REACH Registration % Classification for Limits, M-factors No. (CLP) 1272/2008 and ATEs BENZYL ACETATE 140-11-4 205-399-7 5-<10% EH C3;H412,- oral: ATE = 2490 mg/kg bw CIS-2-TERT- oral: ATE = 4600 BUTYLCYCLOHEXYL 20298-69-5 243-718-1 01-2119970713-33-xxxx 5-<10% EH C2;H411,- mg/kg bw ACETATE (E)-4-(2,6,6- TRIMETHYL-1- 79-77-6 201-224-3 1-<5% EH C2;H411,- oral: ATE = 3940 CYCLOHEXEN-1-YL)-3- mg/kg bw BUTEN-2-ONE ETHYL 4940-11-8 225-582-5 1-<5% ATO 4;H302,- oral: ATE = 1200 HYDROXYPYRONE mg/kg bw PHENETHYL ATO 4-EDI 2;H302- dermal: ATE = 2500 ALCOHOL 60-12-8 200-456-2 01-2119963921-31-xxxx 1-<5% H319,- mg/kg bw-oral: ATE = 1610 mg/kg bw ALPHA-IONONE 127-41-3 204-841-6 1-<5% EH C3;H412,- oral: ATE = 4590 mg/kg bw DIMETHYL-3- SCI 2-EDI 2-SS 1B-EH oral: ATE = 3900 CYCLOHEXENE-1- 27939-60-2 248-742-6 01-2120766006-57-xxxx 0.1-<1% C2;H315-H317-H319- mg/kg bw CARBALDEHYDE H411,- ATO 3-ATD 3-EH A1- M = 10-dermal: ATE = ALLYL HEPTANOATE 142-19-8 205-527-1 0.1-<1% EH C2;H301-H311- 810 mg/kg bw-oral: H400-H411,- ATE = 218 mg/kg bw 3-(2H-1,3- SS 1B-REP 2-EH C2; oral: ATE = 3562 BENZODIOXOL-5-YL) 1205-17-0 214-881-6 01-2120740119-58-xxxx 0.1-<1% H317-H361-H411,- mg/kg bw -2-METHYLPROPANAL METHYL CINNAMATE 103-26-4 203-093-8 0.1-<1% SS 1B;H317,- oral: ATE = 2610 mg/kg bw FL 3-SCI 2-SS 1B-AH LIMONENE 5989-27-5 227-813-5 0.1-<1% 1-EH A1-EH C3;H226- H304-H315-H317- H400-H412,- FL 3-REP 2-AH 1-EH oral: ATE = 3650 GAMMA-TERPINENE 99-85-4 202-794-6 0.1-<1% C2;H226-H304-H361- mg/kg bw H411,- 27 GERANYL ACETATE 105-87-3 203-341-5 01-2119973480-35-xxxx 0.1-<1% SCI 2-SS 1B-EH C3; H315-H317-H412,- LINALYL ACETATE 115-95-7 204-116-4 01-2119454789-19-xxxx 0.1-<1% SCI 2-EDI 2-SS 1B; H315-H317-H319,- TRANS-ROSE 23726-91-2 245-842-1 0.1-<1% SCI 2-SS 1B-EH C2; oral: ATE = 2920 KETONE-2 H315-H317-H411,- mg/kg bw NERYL ACETATE 141-12-8 205-459-2 0.1-<1% SS 1B;H317,- Eye Dam. 1; H318; C ≥ 25%-Eye Irrit. 2; H319; C ≥ 10%-Skin Corr. 1A; H314; C ≥ 90%-Skin FL 3-SCI 1A-EDI 1; ACETIC ACID Corr. 1B; H314; C ≥ 64-19-7 200-580-7 01-2119475328-30-xxxx 0.1-<1% H226-H314,- 25%-Skin Corr. 1C; H314; C ≥ 25%-Skin Irrit. 2; H315; C ≥ 10%- oral: ATE = 3310 mg/kg bw BHT (BUTYLATED 128-37-0 204-881-4 01-2119555270-46-xxxx 0.1-<1% EH A1-EH C1;H410,- HYDROXYTOLUENE) Substances with Community workplace exposure limits: Name Specific Conc. CAS EC REACH Registration % Classification for Limits, M-factors No. (CLP) 1272/2008 and ATEs Eye Dam. 1; H318; C ≥ 25%-Eye Irrit. 2; H319; C ≥ 10%-Skin Corr. 1A; H314; C ≥ 90%-Skin FL 3-SCI 1A-EDI 1; ACETIC ACID Corr. 1B; H314; C ≥ 64-19-7 200-580-7 01-2119475328-30-xxxx 0.1-<1% H226-H314,- 25%-Skin Corr. 1C; H314; C ≥ 25%-Skin Irrit. 2; H315; C ≥ 10%- oral: ATE = 3310 mg/kg bw BHT (BUTYLATED 128-37-0 204-881-4 01-2119555270-46-xxxx 0.1-<1% EH A1-EH C1;H410,- HYDROXYTOLUENE) BUTYL ACETATE 123-86-4 204-658-1 01-2119485493-29-xxxx 0.1-<1% FL 3-STO-SE 3(NE); H226-H336,EUH066 DIETHYL PHTHALATE 84-66-2 201-550-6 01-2119486682-27-xxxx 20-<50% -;-,- FL 2-EDI 2-STO-SE 3 ETHYL ACETATE 141-78-6 205-500-4 0.1-<1% (NE);H225-H319-H336, EUH066 Substances that are endocrine disruptors according to Regulation (EU) 2017/2100 or Regulation (EU) 2018/605, greater than 0.1%: Not Applicable Substances that are persistent, bioaccumulative and toxic or very persistent and very bioaccumulative, greater than 0.1%: Not Applicable Section 4. First-aid measures 4.1 Description of first aid measures Inhalation: Remove from exposure site to fresh air, keep at rest, and obtain medical attention. Eye exposure: Flush immediately with water for at least 15 minutes. Contact physician if symptoms persist. 27 Skin exposure: Remove contaminated clothes. Wash thoroughly with soap and water. Contact physician if irritation persists. Ingestion: Rinse mouth with water and obtain medical attention. 4.2 Most important symptoms and effects, both acute and delayed None expected, see Section 4.1 for further information. 4.3 Indication of any immediate medical attention and special treatment needed None expected, see Section 4.1 for further information. Section 5: Firefighting measures 5.1 Extinguishing media Suitable media: Carbon dioxide, Dry chemical, Foam. 5.2 Special hazards arising from the substance or mixture In case of fire, may be liberated: Carbon monoxide, Unidentified organic compounds. 5.3 Advice for fire fighters: In case of insufficient ventilation, wear suitable respiratory equipment. Section 6. Accidental release measures 6.1 Personal precautions, protective equipment and emergency procedures: Avoid inhalation. Avoid contact with skin and eyes. See protective measures under Section 7 and 8. 6.2 Environmental precautions: Keep away from drains, surface and ground water, and soil. 6.3 Methods and material for containment and cleaning up: Remove ignition sources. Provide adequate ventilation. Avoid excessive inhalation of vapours. Contain spillage immediately by use of sand or inert powder. Dispose of according to local regulations. 6.4 Reference to other sections: Also refer to sections 8 and 13. Section 7. Handling and storage 7.1 Precautions for safe handling: Keep away from heat, sparks, open flames and hot surfaces. - No smoking. Use personal protective equipment as required. Use in accordance with good manufacturing and industrial hygiene practices. Use in areas with adequate ventilation Do not eat, drink or smoke when using this product.